These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33221285)

  • 1. Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Finn AP; Pistilli M; Tai V; Daniel E; Ying GS; Maguire MG; Grunwald JE; Martin DF; Jaffe GJ; Toth CA;
    Am J Ophthalmol; 2021 Mar; 223():338-347. PubMed ID: 33221285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATT.
    Toth CA; Tai V; Pistilli M; Chiu SJ; Winter KP; Daniel E; Grunwald JE; Jaffe GJ; Martin DF; Ying GS; Farsiu S; Maguire MG;
    Ophthalmol Retina; 2019 Apr; 3(4):316-325. PubMed ID: 31014683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Daniel E; Ying GS; Kim BJ; Toth CA; Ferris F; Martin DF; Grunwald JE; Jaffe GJ; Dunaief JL; Pan W; Maguire MG;
    Ophthalmology; 2019 May; 126(5):743-751. PubMed ID: 30476517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Drusen and Hyperreflective Foci as Biomarkers for Disease Progression in Age-Related Macular Degeneration Using Artificial Intelligence in Optical Coherence Tomography.
    Waldstein SM; Vogl WD; Bogunovic H; Sadeghipour A; Riedl S; Schmidt-Erfurth U
    JAMA Ophthalmol; 2020 Jul; 138(7):740-747. PubMed ID: 32379287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR; Abdelfattah NS; Lei J; Shi Y; Marion KM; Morgenthien E; Gune S; Balasubramanian S
    Ophthalmology; 2020 Oct; 127(10):1360-1370. PubMed ID: 32402555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Daniel E; Pan W; Ying GS; Kim BJ; Grunwald JE; Ferris FL; Jaffe GJ; Toth CA; Martin DF; Fine SL; Maguire MG;
    Ophthalmology; 2018 Jul; 125(7):1037-1046. PubMed ID: 29454660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY PARAMETER VARIATIONS AFTER TREATMENT OF MACULAR NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Arrigo A; Aragona E; Bordato A; Amato A; Borghesan F; Bandello F; Parodi MB
    Retina; 2021 Jul; 41(7):1463-1469. PubMed ID: 33315820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye.
    Abdelfattah NS; Zhang H; Boyer DS; Rosenfeld PJ; Feuer WJ; Gregori G; Sadda SR
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1839-46. PubMed ID: 27082298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis.
    Christenbury JG; Phasukkijwatana N; Gilani F; Freund KB; Sadda S; Sarraf D
    Retina; 2018 Jul; 38(7):1276-1288. PubMed ID: 28723848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MACULAR ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Pilot Post Hoc Analysis of Patients With Pigment Epithelial Detachments.
    Rebhun CB; Moreira-Neto C; Gune S; Hill L; Duker JS; Waheed NK
    Retina; 2020 Feb; 40(2):266-272. PubMed ID: 31972796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of age-related macular degeneration with poor response to three loading doses of anti-vascular endothelial growth factor.
    Sariyeva Ismayilov A; Duru Y; Çağlar T; Erseven C; Ulusoy MO
    Int Ophthalmol; 2024 Jun; 44(1):264. PubMed ID: 38913217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics that Correlate with Macular Atrophy in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration.
    Staurenghi G; Cozzi M; Sadda S; Hill L; Gune S
    Ophthalmol Retina; 2023 Apr; 7(4):300-306. PubMed ID: 36372347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.
    Balaratnasingam C; Messinger JD; Sloan KR; Yannuzzi LA; Freund KB; Curcio CA
    Ophthalmology; 2017 May; 124(5):644-656. PubMed ID: 28153442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.
    Cho HJ; Park SM; Kim J; Nah SK; Lee J; Lee DW; Kim JW
    Acta Ophthalmol; 2021 Jun; 99(4):e540-e546. PubMed ID: 32996674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
    Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
    Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.
    Nassisi M; Lei J; Abdelfattah NS; Karamat A; Balasubramanian S; Fan W; Uji A; Marion KM; Baker K; Huang X; Morgenthien E; Sadda SR
    Ophthalmology; 2019 Dec; 126(12):1667-1674. PubMed ID: 31281056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.